FN Form 144 Filed for 9,513 Shares from RSU/PSU Vesting

Rhea-AI Filing Summary

Form 144 notice for Fabrinet (FN) indicates a proposed sale of 9,513 ordinary shares through Bay Crest Partners on the NYSE with an aggregate market value of 3,145,569 and approximately 35,729,581 shares outstanding. The shares to be sold were acquired by the selling person as vested RSU and PSU grants on 08/19/2023 (2,599 shares), 08/20/2023 (4,392 shares) and 08/24/2024 (2,522 shares), matching the total offered for sale.

The notice reports no securities sold by the same person in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer. The form identifies the broker, planned approximate sale date of 08/27/2025, and nature of payment as vesting of equity awards.

Positive

• Full disclosure of transaction details: share counts, acquisition dates, nature of acquisition, broker, and approximate sale date are provided
• Securities were acquired via vesting of RSUs/PSUs, indicating compensation origin rather than an open-market purchase financed by third parties

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice for vested equity—limited immediate material impact on FN's fundamentals.

The Form 144 documents a planned brokered sale of 9,513 shares acquired through compensation vesting. The aggregate value cited (~3.15 million) should be interpreted relative to the issuer's public float and outstanding shares; here the sale size is small versus total outstanding shares (9,513 versus 35.7 million). There are no reported sales by this person in the prior three months, and the filing contains the standard representation about undisclosed material information. This appears to be an administrative disclosure required under Rule 144 rather than a signal of corporate or operational change.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure of vested-equity sale; raises no governance red flags on its face.

The notice shows proceeds will come from vested RSUs/PSUs and names the executing broker. The seller affirms no undisclosed material adverse information, and there are no contemporaneous insider sales reported in the prior three months. From a governance perspective, this aligns with routine executive/employee compensation monetization and required reporting under securities rules; nothing in the notice indicates irregular timing or coordinated disposal beyond normal post-vesting sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Bay Crest Partners, LLC 40 Wall Street 42nd Floor New York NY 10005	9513	3145569	35729581	08/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	08/19/2023	RSU & PSU grants	Fabrinet			2599	08/19/2023	Vesting of RSU & PSU grants
Ordinary Shares	08/20/2023	RSU & PSU grants	Fabrinet			4392	08/20/2023	Vesting of RSU & PSU grants
Ordinary Shares	08/24/2024	RSU & PSU grants	Fabrinet			2522	08/24/2024	Vesting of RSU & PSU grants

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Fabrinet's (FN) Form 144 report?

The Form 144 reports a proposed sale of 9,513 ordinary shares through Bay Crest Partners with an aggregate market value of 3,145,569 and an approximate sale date of 08/27/2025.

How were the 9,513 Fabrinet shares acquired?

All 9,513 shares were acquired as vested RSU and PSU grants on 08/19/2023 (2,599), 08/20/2023 (4,392) and 08/24/2024 (2,522).

Has the seller reported other Fabrinet (FN) sales recently?

The Form 144 states Nothing to Report for securities sold by the person during the past three months.

Which broker is handling the proposed sale?

The broker named in the filing is Bay Crest Partners, LLC, 40 Wall Street, 42nd Floor, New York, NY.

Does the Form 144 indicate any undisclosed material information about Fabrinet?

By signing the notice, the person represents they do not know any material adverse information not publicly disclosed regarding the issuer.